« Previous
Next »
Fertility and Sterility
Volume 85, Issue 5
, Pages 1398-1403
, May 2006
Urinary follicle-stimulating hormone (FSH) is more effective than recombinant FSH in older women in a controlled randomized study
References
- . Birth after the reimplantation of a human embryo . Lancet . 1978;12:366; 2
- . Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins . Lancet . 1984;2:1284–1285
- . Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG . Hum Reprod . 1987;4:309–314
- Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization . Fertil Steril . 1987;47:639–643
- . The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer (a meta-analysis of randomized controlled trials) . Fertil Steril . 1992;58:888–896
- . Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization . Fertil Steril . 1995;63:77–86
- . A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization . Hum Reprod . 1995;10:2534–2540
- Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization (a prospective, randomized, assessor-blind, multicentre trial) . Hum Reprod . 1995;10:3102–3106
- . Superovulation before IVF by recombinant versus urinary human FSH (combined with a long GnRH analog protocol) (a comparative study) . J Assist Reprod Genet . 1995;12:26–31
- . Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH . Fertil Steril . 1996;66:275–280
- . Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP) (results of a randomized comparative study in women undergoing assisted reproductive techniques) . Hum Reprod . 1997;12:2133–2139
- . Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins . Fertil Steril . 1997;68:138–142
- . Outcome from consecutive in-vitro fertilization/intracytoplasmic sperm injection attempts in the final group treated with urinary gonadotrophins and the first group treated with recombinant follicle stimulating hormone . Hum Reprod . 1998;13:1783–1787
- . A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP) in a fixed-dose regimen in women undergoing ovarian stimulation . Hum Reprod . 1999;14:2442–2447
- . Ovarian stimulation during assisted reproduction treatment (a comparison of recombinant and highly purified urinary human FSH) . Hum Reprod . 2000;15:1691–1697
- . Recombinant versus urinary FSH for ovarian stimulation in assisted reproduction . Hum Reprod . 2000;15:1208–1209
- . A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection . Hum Reprod . 2000;15:520–525
- Induction of ovulation in women undergoing assisted reproductive techniques (recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP)) . Hum Reprod . 2000;15:1021–1027
- . Recombinant FSH vs. urinary FSH—retrospective study of matched pairs for type of treatment (IVF or ICSI) . Fertil Steril . 2001;76:1289–1290
- . Comparison of recombinant and urinary follicle-stimulating hormone preparations in short-term gonadotropin releasing hormone agonist protocol for in vitro fertilization–embryo transfer . J Assist Reprod Genet . 2001;18:191–196
- . Clinical experience with recombinant follicle-stimulating hormone (FSH) and urinary FSH (a retrospective case-controlled analysis) . Fertil Steril . 2001;75:920–925
- Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States . Fertil Steril . 2002;77:107–113
- . Follitropin-alpha versus human menopausal gonadotropin in an in vitro fertilization program . Fertil Steril . 2003;80:1094–1099
- . Recombinant FSH vs. urinary FSH for ovarian stimulation in in vitro fertilization . J Reprod Med . 2003;48:799–803
- . Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction . Fertil Steril . 2002;77:711–714
- . Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome (a systematic review based on a Cochrane review) . Hum Reprod . 2003;18:1143–1149
- . Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels . Hum Reprod . 1994;9:806–811
- . Effect of age on response to human menopausal gonadotropin stimulation . J Clin Endocrinol Metab . 1990;71:1525–1530
- . Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol (improved reproductive outcome) . Hum Reprod . 1999;14:1431–1434
- . Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone . Hum Reprod . 2000;15:17–20
-
.
An atlas of human gametes and conceptus
. London (UK): Parthenon Publishing; 1999;
- . Short versus long gonadotropin releasing hormone analogue suppression protocols for superovulation in intracytoplasmic sperm injection patients >40 years . Fertil Steril . 2005;84:644–648
- . Structure-function relationship of recombinant follicle stimulating hormone . (Puregon) Mol Hum Reprod . 1996;2:361–369
- . Increased biological activity due to basic isoforms in recombinant human follicle-stimulating hormone produced in a human cell line . J Clin Endocrinol Metab . 1994;79:756–760
- . Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects . Fertil Steril . 1994;61:62–69
- . Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon) (relationship between serum FSH and efficacy) . Hum Reprod Update . 1996;2:153–161
- . Modulation of serum follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis . J Clin Endocrinol Metab . 1988;67:465–473
- . Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development? . J Clin Endocrinol Metab . 2002;87:5746–5750
- Do cycle disturbances explain the age-related decline of female fertility? Cycle characteristics of women aged over 40 years compared with a reference population of young women . Hum Reprod . 2003;18:495–501
- . Reproductive aging (accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women) . J Clin Endocrinol Metab . 1996;81:1038–1045
The work was performed at: Department of Obstetrics, Gynecology and Perinatology, Policlinico Umberto I Hospital, “La Sapienza” University, Rome, Italy.
PII: S0015-0282(06)00093-8
doi: 10.1016/j.fertnstert.2005.10.049
© 2006 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 85, Issue 5
, Pages 1398-1403
, May 2006

